SCHEMBL24859545

SCHEMBL24859545

CSc1ccc(N2CCO[C@H](CN(C)C)C2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 1/20 0.40
SYK P43405 1/20 0.39
LRRK2 Q5S007 2/20 0.37
TRPA1 O75762 5/20 0.35
GPR119 Q8TDV5 1/20 0.35
MAPT P10636 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
PCSK9 Q8NBP7 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
ALOX15 P16050 1/20 0.33
HTT P42858 1/20 0.33
GAA P10253 1/20 0.33
KDM4E B2RXH2 1/20 0.32
CHEK1 O14757 2/20 0.32
PIM1 P11309 2/20 0.32
PRKACA P17612 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23103282 1.00 DRD4 (0.40) DRD4SYKLRRK2TRPA1GPR119
SCHEMBL23103287 1.00 DRD4 (0.40) DRD4SYKLRRK2TRPA1GPR119
SCHEMBL16440191 0.85 GAA (0.43) SYKLRRK2TRPA1MAPTMEN1
SCHEMBL24495261 0.83 SYK (0.40) SYKLRRK2TRPA1MAPTMEN1
SCHEMBL20457829 0.83 ADORA2A (0.41) DRD4SYKLRRK2GPR119MAPT
SCHEMBL12236016 0.83 SYK (0.42) SYKLRRK2TRPA1MAPTSMN1; SMN2
SCHEMBL2505100 0.83 SYK (0.42) SYKLRRK2TRPA1MAPTSMN1; SMN2
SCHEMBL18436051 0.83 LMNA (0.43) DRD4SYKLRRK2SMN1; SMN2LMNA
SCHEMBL19012754 0.82 TDP1 (0.40) SYKLRRK2TRPA1MAPTSMN1; SMN2
SCHEMBL23114522 0.82 TDP1 (0.40) SYKLRRK2TRPA1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11548890-B1 HPK1 antagonists and uses thereof Nimbus Saturn, Inc. (US) 2023-01-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11548890-B1 HPK1 antagonists and uses thereof PDXK, HIPK1, PCK1 DRD4 4878/4885SYK 4559/4885LRRK2 972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.